QuidelOrtho Corp. (QDEL)
12.58
+0.44
(+3.62%)
USD |
NASDAQ |
Oct 06, 16:00
12.58
0.00 (0.00%)
After-Hours: 19:39
QuidelOrtho Cash from Operations (Quarterly) : -110.60M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -110.60M |
| March 31, 2026 | -33.00M |
| December 31, 2025 | 131.90M |
| September 30, 2025 | -45.50M |
| June 30, 2025 | -46.80M |
| March 31, 2025 | 65.60M |
| December 31, 2024 | 63.70M |
| September 30, 2024 | 117.90M |
| June 30, 2024 | -97.90M |
| March 31, 2024 | -0.70M |
| December 31, 2023 | 80.40M |
| September 30, 2023 | 41.50M |
| June 30, 2023 | -30.60M |
| March 31, 2023 | 188.90M |
| December 31, 2022 | 169.40M |
| September 30, 2022 | -9.70M |
| June 30, 2022 | 224.63M |
| March 31, 2022 | 500.97M |
| December 31, 2021 | 321.38M |
| September 30, 2021 | 77.06M |
| June 30, 2021 | -178.02M |
| March 31, 2021 | 585.46M |
| December 31, 2020 | 439.13M |
| September 30, 2020 | 70.46M |
| June 30, 2020 | 59.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 61.18M |
| December 31, 2019 | 46.99M |
| September 30, 2019 | 13.33M |
| June 30, 2019 | 40.53M |
| March 31, 2019 | 32.90M |
| December 31, 2018 | 43.22M |
| September 30, 2018 | 6.153M |
| June 30, 2018 | 50.65M |
| March 31, 2018 | 35.81M |
| December 31, 2017 | 11.22M |
| September 30, 2017 | -7.523M |
| June 30, 2017 | -5.568M |
| March 31, 2017 | 29.58M |
| December 31, 2016 | 16.62M |
| September 30, 2016 | -2.35M |
| June 30, 2016 | 5.141M |
| March 31, 2016 | -7.66M |
| December 31, 2015 | 14.31M |
| September 30, 2015 | -6.061M |
| June 30, 2015 | -6.77M |
| March 31, 2015 | 31.77M |
| December 31, 2014 | 20.37M |
| September 30, 2014 | 0.186M |
| June 30, 2014 | -4.865M |
| March 31, 2014 | 22.16M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 347.16M |
| Neogen Corp. | 30.20M |
| Aspira Women's Health, Inc. | -2.01M |
| VolitionRX Ltd. | -4.993M |
| Lucid Diagnostics, Inc. | -11.30M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -107.30M |
| Cash from Financing (Quarterly) | 200.60M |
| Free Cash Flow | -211.20M |
| Free Cash Flow Per Share (Quarterly) | -1.993 |
| Free Cash Flow to Equity (Quarterly) | -336.80M |
| Free Cash Flow to Firm (Quarterly) | -73.86M |
| Free Cash Flow Yield | -24.64% |